🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 18 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2013 34,81 35,70 33,99 35,51 +1,66% 4,91% 1.188.100
15/05/2013 35,18 35,28 34,30 34,93 -0,54% 2,79% 650.700
14/05/2013 35,20 35,47 34,42 35,12 +1,44% 2,98% 908.600
13/05/2013 33,62 35,03 33,31 34,62 +2,43% 5,12% 1.262.000
10/05/2013 32,82 33,83 32,01 33,80 +2,18% 5,55% 1.439.300
09/05/2013 32,05 34,34 32,00 33,08 +5,32% 7,30% 2.269.100
08/05/2013 31,64 31,65 30,19 31,41 +0,61% 4,61% 1.153.400
07/05/2013 31,81 32,20 31,05 31,22 -2,04% 3,62% 1.001.700
06/05/2013 31,73 32,24 31,10 31,87 +1,08% 3,59% 1.200.600
03/05/2013 32,98 33,27 31,28 31,53 -3,25% 6,03% 2.036.400
02/05/2013 31,06 33,26 31,06 32,59 +4,62% 7,08% 2.537.500
01/05/2013 30,32 31,40 30,00 31,15 +7,27% 4,62% 2.461.100
30/04/2013 30,15 30,26 28,90 29,04 -3,01% 4,51% 2.088.500
29/04/2013 29,90 30,68 29,37 29,94 +0,47% 4,38% 1.592.200
26/04/2013 30,15 30,99 29,73 29,80 -1,65% 4,18% 1.236.800
25/04/2013 30,22 31,12 29,75 30,30 +0,36% 4,53% 2.067.800
24/04/2013 30,92 30,92 29,53 30,19 -2,36% 4,50% 2.220.100
23/04/2013 32,55 32,75 30,77 30,92 -4,92% 6,08% 3.338.200
22/04/2013 33,90 33,94 31,62 32,52 -1,03% 6,84% 2.425.800
19/04/2013 33,80 34,72 32,78 32,86 -2,64% 5,74% 1.728.000
18/04/2013 35,24 35,50 33,33 33,75 -3,93% 6,16% 1.461.700
17/04/2013 33,94 35,59 33,16 35,13 +3,35% 7,16% 2.145.700
16/04/2013 34,65 34,94 33,06 33,99 -13,38% 5,43% 6.812.100
15/04/2013 40,14 40,71 38,86 39,24 -2,41% 4,61% 3.258.000
12/04/2013 39,03 40,35 38,54 40,21 +2,24% 4,64% 1.453.600
11/04/2013 39,02 40,61 37,26 39,33 +1,24% 8,59% 3.081.600
10/04/2013 40,21 40,25 38,30 38,85 -2,51% 4,85% 2.959.800
09/04/2013 36,28 42,20 35,72 39,85 +11,16% 17,86% 5.922.100
08/04/2013 37,06 37,10 34,88 35,85 -0,99% 5,99% 2.387.600
05/04/2013 34,69 36,94 34,25 36,21 +5,17% 7,75% 3.558.800